Medical News

RSS

Democrats look to Medicare to help finance reform

The Associated Press: "Medicare is looking like a big fat piggy bank for health care overhaul. President Barack Obama and the Democrats want to pay for much of their plan to cover the uninsured by cutting hundreds of billions from the Medicare budget over the next 10 years. From its inception, the health plan for seniors has been kept afloat by taxes out of workers' paychecks. Now, Medicare savings would count toward helping uninsured working-age children and grandchildren afford their own coverage."

29 Sep 2009

NIH awards Novelos and MGH $1M grant for the study of compounds for radiation-induced lung injury

Novelos Therapeutics, Inc. (OTCBB: NVLT), a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, today announced that the Massachusetts General Hospital (MGH), in collaboration with Novelos, was awarded a $950,371 competitive grant by the National Institutes of Health (NIH) to study two Novelos compounds – NOV-002 and NOV-205 – for the mitigation and treatment of radiation-induced pulmonary injury.

29 Sep 2009

Solos to supply MammoView surgical endoscopy instruments for Beth Israel Medical Center

Solos Endoscopy, Inc. (Pink Sheets: SNDY) is pleased to announce that the Company has received purchase orders for the MammoView(TM) line of surgical endoscopy instruments from Beth Israel Medical Center, one of the five Continuum Health Partners health care facilities that play a vital role in providing quality medical care for millions of New Yorkers.

29 Sep 2009

Share repurchase program announced by Synovis Life Technologies

Synovis Life Technologies, Inc. (Nasdaq: SYNO), a leading biomaterial and surgical products company, today announced that its board of directors has approved a program for the company to repurchase up to 500,000 shares of its common stock.

29 Sep 2009

AAP receives grant to promote awareness on childhood obesity

The American Academy of Pediatrics (AAP) announces that it has been awarded a $250,000 grant from MetLife Foundation, to promote community and regional approaches to obesity prevention. Through the grant, AAP will launch two national grant programs, which are focused on encouraging both established pediatricians and pediatricians-in-training to develop collaborative methods to educate communities about the health effects of childhood obesity.

29 Sep 2009

Renewed GMP certification for China Biologic Products' Qianfeng subsidiary

China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("China Biologic," or the "Company"), one of the leading plasma-based pharmaceutical companies in the People's Republic of China ("PRC"), today announced that on September 2, 2009, the PRC's State Food and Drug Administration (the "SFDA") renewed SFDA certification of compliance with Good Manufacturing Practices ("GMP") for the production facility of Qianfeng Biological Products Co., Ltd. ("Qianfeng"), China Biologic's indirectly owned subsidiary.

29 Sep 2009

San Francisco Medical Center acquires a BSD-500 Hyperthermia System

BSD Medical Corporation announced today that the University of California, San Francisco Medical Center (UCSF) has acquired a BSD-500 Hyperthermia System (BSD-500). UCSF is a world leader in hyperthermia and has the largest and most versatile hyperthermia program on the West Coast, and its world-renowned Radiation Oncology team has added the capabilities of the BSD-500 to its growing hyperthermia cancer treatment program.

29 Sep 2009

90-day supply program to improve overall healthcare

Walgreens (NYSE:WAG) today launched a broad initiative for 90-day prescriptions that promotes delivery of maintenance and chronic care medication through its national network of more than 7,000 community pharmacies and employer worksite centers.

29 Sep 2009

pSivida reports interim results of human PK study of Iluvien

pSivida Corp, a leading drug delivery company that has developed two of the only three products approved by the FDA for the long-term, sustained release delivery of drug to treat chronic back of the eye disease, today reported the interim 18-month safety and efficacy results from the first human pharmacokinetic study (PK Study) of Iluvien®. The PK trial is being conducted by Alimera Sciences, the licensee for Iluvien.

29 Sep 2009

Doctations launches blog to improve healthcare

Doctations, Inc., an innovative leader in applying Internet technology to improve healthcare, today announced the launch of its new DocPatient blog. Weekly postings to the blog site by company executives and thought leaders will address timely healthcare related topics, express expert opinions and pose provocative questions intended to inform the community, stimulate constructive dialogue and promote healthcare improvement.

29 Sep 2009

Synta commences Phase 1/2 clinical study of novel Hsp90 inhibitor in hematologic malignancies

Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that it has initiated a Phase 1/2 clinical study of its novel heat shock protein 90 (Hsp90) inhibitor, STA-9090 in hematologic malignancies with a once-a-week dosing schedule.

29 Sep 2009

iposture launches posture improvement device for golfers

Memphis-based neurologist Moacir Schnapp, M.D., creator of the iPosture, today announced the launch of his posture improvement device for golfers – the iPosture Golf-Pro.

29 Sep 2009

Acrux reports Phase III trial results evaluating AXIRON for testosterone deficiency

Australian company, Acrux, today announced positive results from a Phase III trial evaluating the safety and efficacy of AXIRON™ in 155 men with testosterone deficiency (hypogonadism), across 26 sites in six countries.

29 Sep 2009

Aurora Breast MRI and Clear Channel Radio join to support The Wellness Community fundraiser

Aurora Breast MRI of Sarasota today announced it has partnered with Clear Channel Radio for a fundraising effort to benefit The Wellness Community of Southwest Florida. The fundraiser, titled “Change for Change,” will consist of a series of breast cancer awareness messages throughout the month of October to encourage donations at area “Change for Change” locations.

29 Sep 2009

Local officials address long-term costs associated with employee and retiree health care

About 49 percent of the nations’ cities, counties and townships expect less revenue in 2010, and 21 percent expect fewer employees, according to a new survey.

29 Sep 2009

1-800-DENTIST launches nationwide smile makeover contest

As an advocate of regular dental care, 1-800-DENTIST® understands that many people can't afford the dentistry they need. That's why the nation's leading free resource for consumers in search of a dentist has launched a nationwide $30,000 smile makeover contest called "My Smile Bites." To enter, contestants must upload a personal video showing what's wrong with their smile, explaining how these problems affect their lives. Video submissions will be accepted through November 10, 2009 noon PST.

29 Sep 2009

Multiple Sclerosis Society of Canada invites schools to participate in the 32nd MS Read-A-Thon

Multiple Sclerosis Society of Canada, Quebec Division is happy to announce the 32nd edition of the MS Read-A-Thon. This event invites students in elementary and secondary schools across the province to participate in an enjoyable activity that gives them a chance to develop their philanthropic qualities while stimulating their interest in reading.

29 Sep 2009

New Jersey hopsital chooses JAOtech's embedded Smart Terminals

Holy Name hospital of Teaneck, New Jersey has selected JAOtech Smart Terminals for its second generation bedside entertainment and communication system.

29 Sep 2009

Scarab Genomics releases new E. Coli strain

ScarabXpress is the latest strain in the multiple-deletion series (MDS) of Scarab Genomics Clean Genome® E. coli. Based on the MDS™42 strain, ScarabXpress T7lac contains a chromosomal copy of the T7 RNA polymerase gene expressed from a unique, tightly controlled lac promoter.

29 Sep 2009

Elan Corporation intends to offer senior fixed rate notes due 2016

Elan Corporation, plc today announced that its wholly-owned subsidiaries, Elan Finance public limited company and Elan Finance Corp., intend to offer, subject to market conditions, US$600 million in aggregate principal amount of senior fixed rate notes due 2016 (the “New Notes”).

29 Sep 2009